Please Wait...


Upcoming Webinars:

April 5, 2018 - 11:00am (EDT)

Missing patients, and therefore their data, pose a threat to clinical trials. This missing patient data increases the risk of additional queries from regulatory agencies regarding the potential effect on the endpoint data and therefore the significance of the safety and efficacy findings. Study sites often lack the resources and time to find patients who are lost to follow-up (LTFU).

On Demand Webinars by Category

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join @bioclinica's Research Dev. Dir. Marieke Cajal, PhD @adpdnet 3/18 where she will speak on patient engagement…
bioclinica (22 hours ago)
Still on the fence about #eSource? Here R some key considerations & inside tips for successful implementation & how…
bioclinica (Yesterday)
Almost here! #ASCPT2018 Tour central Florida's premier Phase 1 facility at our Open House 3/22! Meet our team & see…
bioclinica (Yesterday)
RT @FDAWomen: Today we welcomed minority health stakeholders during FDA’s first Minority Health Listening Session. Thank you for this discu…
bioclinica (Yesterday)
RT @melfass: The House has rejected the "Right to Try" bill, opponents of which said would have compromised the #clinicaltrials process. cc…
bioclinica (Yesterday)
RT @eClinical_Jen: Here what the FDA has to say on using Microsoft Excel for Clinical Trial data: #eHealth #Pharm…
bioclinica (Yesterday)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen